Simon
Senior Member
- Messages
- 3,789
- Location
- Monmouth, UK
I think that's the nub of it. I agree re case definition and think that's something that has to be sorted before the project progresses and is the area most likley to be affected by the lopsided selection of mecfs experts in MEGA.Problem is that the potential good elements of the study do not nullify the bad elements in the study. They simply co-exist. I am unconvinced the trade off is worth it.
But overall, this is worth it for me, primarirly because I think the biomded work on the huge sample (as well as the huge sample itself) is just what's needed to make major inroads into understading this illness, including subgroups. And also because I think closing MEGA down would harm biomedical research in the UK.
But I understand that others don't think the trade off is worth it.